Cigna Group Analysts Show Mixed Ratings and Price Targets

Cigna Group faces mixed analyst ratings as sentiments shift. Analysts evaluate its current performance, revealing an 8.16% decrease in average price target. This reflects changing perceptions in the market, potentially affecting investor confidence and stock performance.

Date: 21-03-2025

AI Rating: 5

Analyst Ratings and Market Performance
Recent ratings for Cigna Group (NYSE: CI) indicate varied analyst sentiments, with 4 bullish, 7 somewhat bullish, and 1 indifferent rating out of 12 provided. This mix reflects uncertainty in performance expectations and can impact stock prices.

The average 12-month price target for Cigna Group now stands at $366.00, accompanied by a high estimate of $390.00 and a low estimate of $339.00. However, analysts have reduced the average price target by 8.16%, signaling declining confidence in the stock's short-term prospects.

Key Financial Metrics
Cigna's latest performance showcases noteworthy metrics:

Revenue Growth: Achieved an impressive revenue growth rate of 28.66% as of December 31, 2024, surpassing competitors in the health care sector.
Net Margin: Cigna's net margin stands at 2.17%, exceeding industry averages, indicating effective cost management and profitability.
Return on Equity (ROE): With an ROE of 3.43%, Cigna's performance highlights challenges in leveraging equity for returns, falling below industry averages.

Understanding these metrics alongside analyst evaluations provides a comprehensive view of Cigna Group's market position. While analysts adjust recommendations based on market dynamics, the company's strong revenue growth and net margin may bolster future performance despite the concerns reflected in reviews and ratings.

Stocks: CI